Viewing StudyNCT00343733



Ignite Creation Date: 2024-05-05 @ 4:54 PM
Last Modification Date: 2024-10-26 @ 9:25 AM
Study NCT ID: NCT00343733
Status: COMPLETED
Last Update Posted: 2014-05-09
First Post: 2006-06-21

Brief Title: Study to Evaluate the Efficacy and Safety of OraVescent Fentanyl Citrate Treatment for the Management of Breakthrough Pain in Opioid-Tolerant Patients With Noncancer-Related Chronic Pain
Sponsor: Cephalon
Organization: Teva Branded Pharmaceutical Products RD Inc

Conditions & Keywords Data

Conditions:
Name
Pain
Keywords:
Name View
postherpetic neuralgia View
back pain View
fibromyalgia View
diabetic peripheral neuropathy View
traumatic injury View
complex regional pain syndrome View
neck pain View
chronic pancreatitis View
osteoarthritis View